Novo Nordisk South Africa leads industry as a ‘best place to work’

Primary tabs

Novo Nordisk South Africa leads industry as a ‘best place to work’

South Africa names the best places to work and Novo Nordisk takes the pharmaceutical industry top spot.
tweet me:
USA, Denmark, Argentina, France, Poland & now South Africa! Novo Nordisk is a 'Best Place to Work' @novonordisktbl http://3bl.me/2syawg

Multimedia from this Release

Lula Danster, Financial Manager, Novo Nordisk South Africa

Tuesday, October 8, 2013 - 11:15am

CONTENT: Press Release

October 8, 2013 /3BL Media/ - On 3 October 2013, Novo Nordisk South Africa was ranked number 1 in the Deloitte Best Company to work for survey of 2013 in the Chemical and Pharmaceutical category.

The survey, which has been running for 14 years, analyses the input of employees from 113 companies to ascertain which company they consider to be the best employer to work for.

“We are delighted that Novo Nordisk South Africa has been recognised in our industry sector,” says Dr. Timmy Kedijang, general manager, Novo Nordisk South Africa. “The recognition could not have come at a better time, as Novo Nordisk celebrates its 90th anniversary this year. Our Danish founders began a journey to change diabetes in 1923. Today, we have thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat, and ultimately cure diabetes.”

Earlier this year, Novo Nordisk in the United States was ranked 48th in FORTUNE Magazine’s 2013 “100 Best Companies to Work For” list and was also included on the 2013 Best Adoption-Friendly Workplaces List. Additionally, Novo Nordisk operations globally have been ranked among the best places to work in Denmark, Argentina, France and Poland.

About Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. For more information, visit novonordisk.com/sustainability.

Keywords: Research, Reports & Publications | Diversity & Inclusion | Great Place to Work | Health & Healthcare | Novo Nordisk | Research, Reports & Publications | Social Impact & Volunteering | South Africa | csr | diabetes | sustainability

CONTENT: Press Release

parse.ly